Medical Polymers Market Size
Medical polymers are the collective term used in a different contexts in healthcare and medical application for biodegradable plastic, elastomers such as thermoplastic elastomers, and natural & polymers like resins and fibers. Polymers are significant part of the healthcare system due to better biocompatibility, low cost, and less weight. Polymers are extensively employed in medical industry including surgical instruments, catheters, implants, accessories, and diagnostic systems. Medical polymers are mainly utilized to manufacture facial implants, vascular grafts, dental implants, intraocular lenses, contact lenses, prosthetic heart valves, vascular skin implants, and breast implants.
Market Highlights
Global Medical Polymers is expected to project a notable CAGR in 2030.
to surpass USD 36.78 billion by 2030 from USD 16.14 billion in 2020 at a CAGR of 8.59% in the coming years, i.e., 2021-30. Mounting adoption of polymers for implants is driving the growth of the global Medical Polymers market. Other factors that are driving the growth of the market include escalating demand for lightweight, high-strength plastic materials and enhancement in polymers and composites employed in components such as surgical instrument handle, syringes, and catheters. In addition, continuously rising demand for pharmaceutical devices is contributing in the growth of medical polymers market.
Recent Highlights in Global Medical Polymers
-
In March 2020, Eastman launched “Tritan MXF” a next-generation copolyester which provides chemical resistance, higher impact strength, and easier processability for the housing and hardware of electronic medical devices.
-
In April 2018, BASF opened a new production line for its high-temperature resistant thermoplastic “Ultrason” at its site in Yeosu, Korea.
Global Medical Polymers: Segments
Medical resins and fibers segment to grow with the highest CAGR during 2020-30
Global Medical Polymers is segmented by Product Type into Medical resins and fibers, Medical elastomers, Biodegradable plastics, and Other. Medical resins and fibers, segment held the largest market share in the year 2019. Medical resins and fibers involve polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS), and other thermoplastics. Fibers and resins are extensively used in several applications including cranial injuries, spinal implants, and hip and joint replacements on account of enhanced biocompatibility and low cost.
Medical Devices & Equipment segment to grow with the highest CAGR during 2020-30
Global Medical Polymers is divided by Source into Medical Devices & Equipment and Medical Packaging. Medical Devices & Equipment, segment held the largest market share in the year 2020 and will continue to dominate the market in the coming years. The growth of the segment of the market is driven by the rapidly increasing population along with the prevalence of chronic diseases. Moreover, rising consumer healthcare expenditure particularly in emerging economies is projected to fuel the medical devices and equipment segment. Also, negligible chemical corrosion and easy cleaning methods of medical polymers is likely to boost the product demand in the coming years.
Market Dynamics
Drivers
Surging Demand for Pharmaceutical Devices
Constantly growing demand for pharmaceutical devices is the key factor propelling the global medical polymers market. The development of innovative medical devices, rising prevalence of cardiovascular diseases, increasing occurrences of infections and other diseases, and growing general awareness is boosting the pharmaceutical device industry. This in turn is expected to augment the growth of medical polymers market. Presently polyetherimide, polyphenylsulfone, polysulfone, and polyether ether ketone are extensively used for several applications in the pharmaceutical device market.
Superior Properties as Compared to Available Substitutes
Over the last few years, polymers are gaining popularity in medical sector due to the advancements in the engineering plastics, such as PEEK, PMMA, PET, and ABS. These plastics are ideal to use in medical appliances and devices since they meet safety requirements. Engineering plastics utilized as medical polymers can match the stability, durability, structural strength, formability, and inertness of ceramics and metals as being more resource-effective and lighter. Besides medical polymers are available at cheap prices as compared to other substitutes including metals, glass, and ceramics. In addition, medical polymers find their application in packaging also owing to lightweight, durability, cost-effectiveness, and transparency which is boosting the demand for medical polymers.
Restraint
Unstable Prices of Raw Material
Varying prices of raw materials is the major factor that is likely to hamper the global medical polymers market in the near future. The prices are fluctuating due to the unpredictable energy prices. In 2018, as per the BP Statistics average price of oil increased from $54/bbl. to $71/ bbl. in 2017. Furthermore, rigorous regulations levied by several medical organizations in regard with product quality and prices is expected to restrict the medical polymers market growth.
Global Medical Polymers: Key Players
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
- Bayer Material Science AG,
- Celanese Corporation,
- DSM N.V.,
- E. I. du Pont de Nemours Company,
- Eastman Chemical,
- Evonik Industries AG,
- Exxon Mobil Corporation,
- The Dow Chemical Company,
- Huizhou Foryou Medical Device Co. Ltd.,
- Kraton Performance Polymers Inc.,
- Other Prominent Players
Global Medical Polymers: Regions
Global Medical Polymers is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and Middle East, and Africa. Global Medical Polymers in North America held the largest market share in the year 2019. North America will continue to dominate the global Medical Polymers owing to rising healthcare expenditure and the rising awareness about health and fitness among consumers. Besides, growing occurrence of chronic diseases and rising geriatric population in the region is predicted to proliferate the Medical Polymers market. Furthermore, flourishing pharmaceutical packaging industry in the region and increasing number of spinal implants is inducing regional market growth.
Global Medical Polymers is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Global Medical Polymers report also contains analysis on:
Medical Polymers Segments:
- By Product Type
- Medical resins and fibers
- Medical elastomers
- Biodegradable plastics
- Other
- By Application
- Medical Devices & Equipment
- Medical Packaging
- Medical Polymers Dynamics
- Medical Polymers Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
Frequently Asked Questions (FAQ):
Medical polymers market encompasses polymeric materialsāsuch as fibers, resins, elastomers and biodegradable plasticsāused in medical devices, implants, packaging, wound care, diagnostics, drug-delivery systems and other healthcare applications.
Market was valued around USD 23.3 billion in 2024 and is projected to reach approximately USD 40.9 billion by 2033, reflecting a compound annual growth rate (CAGR) near 6.1% from 2025ā2033.Some other estimates suggest growth to USD 60.5 billion by 2029 at a CAGR of about 8.0%.
By application, the medical components (medical devices & instruments) segment holds the largest share owing to high demand for lightweight, durable and biocompatible materials in device manufacturing.
Major global companies operating in this market include BASF SE, Celanese Corporation, Evonik Industries AG, SABIC, DSM N.V., Eastman Chemical Company and Covestro AG.
Key growth drivers include rising prevalence of chronic diseases and aging populations, increasing demand for minimally invasive and disposable medical devices, advancements in polymer technology (including biocompatible and bioresorbable solutions), growing healthcare infrastructure investment and greater focus on patient safety and infection control.
Select License Type